Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Techne (TECH) Accumulated Expenses (2016 - 2025)

Bio-Techne (TECH) has 16 years of Accumulated Expenses data on record, last reported at $20.3 million in Q4 2025.

  • For Q4 2025, Accumulated Expenses fell 62.05% year-over-year to $20.3 million; the TTM value through Dec 2025 reached $20.3 million, down 62.05%, while the annual FY2025 figure was $25.7 million, 3.12% up from the prior year.
  • Accumulated Expenses reached $20.3 million in Q4 2025 per TECH's latest filing, up from $19.2 million in the prior quarter.
  • Across five years, Accumulated Expenses topped out at $62.0 million in Q2 2022 and bottomed at $13.8 million in Q3 2022.
  • Average Accumulated Expenses over 5 years is $29.3 million, with a median of $23.0 million recorded in 2024.
  • Peak YoY movement for Accumulated Expenses: crashed 75.98% in 2023, then skyrocketed 247.61% in 2025.
  • A 5-year view of Accumulated Expenses shows it stood at $19.0 million in 2021, then soared by 50.77% to $28.6 million in 2022, then increased by 15.23% to $33.0 million in 2023, then skyrocketed by 62.43% to $53.6 million in 2024, then tumbled by 62.05% to $20.3 million in 2025.
  • Per Business Quant database, its latest 3 readings for Accumulated Expenses were $20.3 million in Q4 2025, $19.2 million in Q3 2025, and $25.7 million in Q2 2025.